Meeting
2016 Genitourinary Cancers Symposium
The effect of stereotactic ablative radiotherapy on time to change of systemic therapy in extra-cranial renal cell carcinoma metastases.
Authors
Chiachien Jake Wang
The University of Texas Southwestern Medical Center, Dallas, TX
Chiachien Jake Wang , Xin Cai , Dong W. Kim , Lorel Huelsmann , Jeffrey John Meyer , Ivan Pedrosa , James Brugarolas , Vitaly Margulis , Robert D. Timmerman , Raquibul Hannan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 533)
DOI
10.1200/jco.2016.34.2_suppl.533
Abstract #
533
Poster Bd #
E16
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer.
First Author: Yuanyuan Zhang
Poster
2024 ASCO Genitourinary Cancers Symposium
Time to next systemic therapy after stereotactic body radiation therapy for oligoprogressive metastatic castrate-resistant prostate cancer.
First Author: Corbin J. Eule
Poster
2024 ASCO Genitourinary Cancers Symposium
Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).
First Author: Raquibul Hannan
Poster
2024 ASCO Genitourinary Cancers Symposium
Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.
First Author: Young Suk Suk Kwon